
|Articles|September 1, 2013
Long-term follow-up outcomes favourable for bifocal corneal inlay
Results from 2 years of follow-up demonstrate the efficacy of a bifocal corneal inlay for correcting presbyopia in emmetropic patients.
Advertisement
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times Europe
1
How Digital Workflow Boosted my Confidence and Elevated Premium Patient Rates in Cataract Surgery
2
From skepticism to clarity and focus: A family’s PRESBYOND experience
3
Patent granted to Kiora Pharmaceuticals' KIO-100 formulations
4
Celltrion’s EYLEA-referencing biosimilar, EYDENZELT, receives Canadian approval
5















































